It was as recently as February that biotech CEOs were talking enthusiastically to Fierce about a positive “shift in the ...

The Spanish government has announced a goal to raise a $200 million venture capital fund as part of a biotech initiative ...

Terremoto Biosciences has spelt out how the California biotech will use a $108 million series C round to continue its efforts ...

While fentanyl overdose deaths have been falling in recent years, use of the drug remains a major public health crisis in the ...

The former leaders of SpringWorks Therapeutics are back with a new biotech venture that is already buzzing from a $300 ...

The FDA’s recently unveiled plausible mechanism framework may have been forged with i | The FDA’s newly launched plausible ...

Harbinger Health has grabbed $100 million in its latest funding round as the company reveals a new Resolve in its cancer ...

After initiating a wind-down more than 18 months ago and exploring liquidation, Galera Therapeutics has found a path forward ...

Eli Lilly's acquisition spree shows no sign of stalling, although the Big Pharma is keeping the terms of its latest buy ...

Takeda has pulled back from a research collaboration with a fellow Japanese life sciences company, ending work to discover ...

Stryker is picking up vascular devices maker Amplitude Vascular Systems while Avanos Medical is being taken private in a ...

Californian protein sequencing company Alamar Biosciences is seeking an IPO worth up to $159 million amid a growing boom in ...